Clinical Trial Update: A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma [Phase 1]

View source ↗

Summary

The Phase 1 study of INCB059872 in Ewing sarcoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• INCB059872

Snippet

Sponsor: Incyte Corporation | Conditions: Relapsed Ewing Sarcoma | Phase 1 | Status: TERMINATED